Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cryptic redundancy between PAR1b and PAR1a, two members of the PAR1 kinase family, in the survival of PAR1b-knockout mice

ABSTRACT: The PAR1/MARK family of serine/threonine kinases (Par1a-d) redundantly regulates cell polarity. Furthermore, PAR1b facilitates nuclear translocation of BRCA1 through phosphorylation. Within the nucleus, BRCA1 protects stalled replication forks and repairs DNA double-strand breaks through homologous recombination. Consequently, BRCA1-knockout mice are embryonically lethal. In contrast, conventional PAR1b-knockout mice reach adulthood, suggesting a compensatory mechanism for PAR1b in regulating BRCA1 in these knockout mice. Here we find that while PAR1b knockout leads to the death of wild-type mouse embryonic fibroblasts (MEFs), PAR1b-null MEFs can be readily established from conventional PAR1b-knockout mice. In PAR1b-null MEFs from PAR1b-knockout mice, PAR1a, but not PAR1c or PAR1d, is essential for cell survival. Thus, PAR1a-mediated cryptic redundancy is unleashed only when functional PAR1b is absent from the onset of embryogenesis, which induces epigenetic changes in gene regulation. This study presents the first evidence of cryptic redundancy driven by epigenetic modifications in the regulation of gene expression during early embryogenesis.

ORGANISM(S): Mus musculus

PROVIDER: GSE306867 | GEO | 2026/02/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Cryptic redundancy between PAR1b and PAR1a, two members of the PAR1 kinase family, in the survival of PAR1b-knockout mice

Project description:Cryptic redundancy between PAR1b and PAR1a, two members of the PAR1 kinase family, in the survival of PAR1b-knockout mice

| PRJNA1312816 | ENA

G0S2 functions as a tumor supressor through represssion of Myc signaling pathways

Project description:Comparions on gene expression in murine embyonic fibroblasts (MEFs) wild-type vs G0S2 null MEFs Total RNA obtained from spontanously immortalized MEF cell line E2 from wild-type C57BL/6 mice (E2) and spontaneously immortalized MEF cell line E6 from G0S2 knockout C57BL/6 mice; MEF lines were used at passage number 10-12

2016-06-01 | E-GEOD-74696 | biostudies-arrayexpress

Expression Data from wild type and E2F4 null MEFs

Project description:We have used primary MEFs derived from wild type and E2F4 null mice growing asynchrounously in serum to generate a signature for E2F4 pathway activation. 10 wild type and 10 E2F4 null samples were each assayed using the Affymetrics Mouse Genome 430A 2.0 array. Keywords: Primary MEFs from wild type and E2F4 null mice

2008-07-11 | GSE11039 | GEO

Brain BRCA1 conditional knockout

Project description:BRCA1 nestin CRE conditional knockout cortrices of P7 animals were compared to wildtype littermates to characterize the mutant phenotype. Keywords: expression BRCA1 conditional knockouts using nestin CRE and a null allele with an inverted neo cassette at the 5' end of the exon 11 of BRCA1 on one floxed allele flanking exons 5-13. Cortices of 3 wildtype animals were compred to 3 BRCA cKO at postnatal day 7.

2011-09-07 | E-GEOD-6310 | biostudies-arrayexpress

Single cell RNA-sequencing of testes from control and Brca1 germ cell-specific knockout mice

Project description:To examine the role of BRCA1 during the formation of undifferentiated spermatogonia, we generated Brca1 germ cell-specific knockout mice, in which BRCA1 was undetectable when undifferentiated spermatogonia started to form at PD1. To analyze the defects comprehensively, we isolated testes from one pair of control and Brca1 germ cell-specific knockout mice male mice at PD7 and performed single-cell RNA sequencing (scRNA-seq) analyses using the 10× Genomics platform. In the study, we found that BRCA1 loss indeed disrupts early postnatal germ cell development.

2025-05-19 | GSE273607 | GEO

Expression profiling in primary embryonic fibroblasts deficient for the lats2 locus

Project description:We previously reported LATS2 null mice (Yabuta et al., 2007). LATS2 known as a tumor suppressor protein. However, the LATS2 mediated transcriptional regulation remains largely unknown. To investigate potential signaling pathways, we performed the expression profiling by using primary MEFs derived from wild type and LATS2 null mice.

2016-10-16 | GSE25536 | GEO

The effect on gene expression of Smchd1 deletion in primary MEFs, transformed MEFs and MEF tumours

Project description:Smchd1 appears to act as a tumour suppressor in the transformed fibroblast model. We find gene expression differences are most pronounced in the transformed MEFs. We always detect a small number of clustered genes and imprinted genes as differentially expressed, along with others involved in tumorigenesis. The microarrays compared Smchd1 null and Smchd1 wildtype samples from different cell types (primary MEFs, transformed MEFs, tumours derived from transformed MEFs). Wildtype mice are FVB/N and Smchd1 null mice have the MommeD1 point mutation on a FBV/N background.

2012-09-30 | E-GEOD-40734 | biostudies-arrayexpress

Heterozygous BRCA1 Deletion, but not Complete BRCA1 Loss, Confers Resistance to Androgen Deprivation Therapy in Prostate Cancer

Project description:BRCA1 is biallelically deleted or mutated in at least 1.9% of prostate tumors, but whether BRCA1 deficiency influences resistance to androgen deprivation therapy (ADT) and prostate cancer development remains elusive. Here we surprisingly find that in human, BRCA1 heterozygous deletion is observed in approximately 13% of human prostate cancers, is more prevalent in neuroendocrine prostate tumors and predicts worse survival than BRCA1 homozygous deletion. In mice, we show that Brca1 heterozygosity (HET) but not Brca1 full inactivation (KO) accelerates early tumor development, invasion and resistance to ADT in Pten-null prostate tumors. Furthermore, pre-malignant tumors and organoids derived from Brca1 HET mice undergo neuroendocrine differentiation and exhibit elevated levels of the unfolded protein response potentially as a pro-survival mechanism, but not those of Brca1 KO. Our findings thus provide important insights into clinical management of prostate cancer patients, suggesting that patients heterozygous for Brca1 are prone to developing resistance to ADT and should be treated differently from patients with complete Brca1 loss.

2024-02-01 | GSE176280 | GEO

Transcription profiling of mouse embyronic fibroblasts from wild type and E2F2 null mice to generate a signature for E2F2 pathway activation

Project description:We have used primary MEFs derived from wild type and E2F4 null mice growing asynchrounously in serum to generate a signature for E2F4 pathway activation. 10 wild type and 10 E2F4 null samples were each assayed using the Affymetrics Mouse Genome 430A 2.0 array. Experiment Overall Design: MEFs from 3 wild type embryos on a total of 10 cultutes were grown and harvested for RNA. MEFS from 5 E2F4 null embryos were grown on a total of 10 cultures.

2008-10-24 | E-GEOD-11039 | biostudies-arrayexpress

G0S2 functions as a tumor supressor through represssion of Myc signaling pathways

Project description:Comparions on gene expression in murine embyonic fibroblasts (MEFs) wild-type vs G0S2 null MEFs

2016-06-01 | GSE74696 | GEO